ConductScience.org, home

Paper23397358

Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis.

Zhang L and 5 others. J Cancer Res Clin Oncol, 2013. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis. Papers, record 23397358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23397358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2025-07-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang LLei
2Wu XXiaojun
3Xu TTao
4Luo CChun
5Qian JJun
6Lu YYicheng

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
GliomaMajor topic
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Humans
Odds Ratio
Publication Bias
Radiotherapy
Survival Analysis

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115800329Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.J Clin Oncol2005https://conductscience.org/library/papers/15800329PubMed
216782910Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.J Clin Oncol2006https://conductscience.org/library/papers/16782910PubMed
311208845Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.J Clin Oncol2001https://conductscience.org/library/papers/11208845PubMed
418395280Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.Radiother Oncol2008https://conductscience.org/library/papers/18395280PubMed
520017960Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.BMC Cancer2009https://conductscience.org/library/papers/20017960PubMed
619901110NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol2009https://conductscience.org/library/papers/19901110PubMed
722539339Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).Neuro Oncol2012https://conductscience.org/library/papers/22539339PubMed
811937180Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.Lancet2002https://conductscience.org/library/papers/11937180PubMed
919783377Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.Int J Radiat Oncol Biol Phys2010https://conductscience.org/library/papers/19783377PubMed
1019747048Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis.J Neurosurg2010https://conductscience.org/library/papers/19747048PubMed
1118248979Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).Eur J Cancer2008https://conductscience.org/library/papers/18248979PubMed
1216782911
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
J Clin Oncol2006https://conductscience.org/library/papers/16782911PubMed
1315758009Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med2005https://conductscience.org/library/papers/15758009PubMed
1412958120Measuring inconsistency in meta-analyses.BMJ2003https://conductscience.org/library/papers/12958120PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
41398312The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics.Nat Rev Chem2026https://conductscience.org/library/papers/41398312PubMed
40598793Comparative efficacy of glioma treatment strategies: an umbrella review of meta-analyses.Ann Med2025https://conductscience.org/library/papers/40598793PubMed
32811802Effect of Podophyllotoxin Conjugated Stearic Acid Grafted Chitosan Oligosaccharide Micelle on Human Glioma Cells.J Korean Neurosurg Soc2020https://conductscience.org/library/papers/32811802PubMed
32226508Long Noncoding RNA LINC00467 Promotes Glioma Progression through Inhibiting P53 Expression via Binding to DNMT1.J Cancer2020https://conductscience.org/library/papers/32226508PubMed
31681604MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings.Front Oncol2019https://conductscience.org/library/papers/31681604PubMed
29095287A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: A systematic review and meta-analysis.Medicine (Baltimore)2017https://conductscience.org/library/papers/29095287PubMed
27049919microRNA-149 targets caspase-2 in glioma progression.Oncotarget2016https://conductscience.org/library/papers/27049919PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23397358

GET https://conductscience.org/api/papers/v1/23397358/authors